BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 34234415)

  • 1. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
    Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
    J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Targeted Curcumin Delivery by Folate-Modified MPEG-PCL Self-Assembly Micelles for Colorectal Cancer Therapy.
    Hu Y; He Y; Ji J; Zheng S; Cheng Y
    Int J Nanomedicine; 2020; 15():1239-1252. PubMed ID: 32110020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid decorated magnetic nanosponge: An efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging.
    Gholibegloo E; Mortezazadeh T; Salehian F; Forootanfar H; Firoozpour L; Foroumadi A; Ramazani A; Khoobi M
    J Colloid Interface Sci; 2019 Nov; 556():128-139. PubMed ID: 31437658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
    Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
    Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.
    Zhang Y; Zhou J; Yang C; Wang W; Chu L; Huang F; Liu Q; Deng L; Kong D; Liu J; Liu J
    Int J Nanomedicine; 2016; 11():1119-30. PubMed ID: 27051287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
    Wang WY; Cao YX; Zhou X; Wei B
    Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
    [No Abstract]   [Full Text] [Related]  

  • 11. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery.
    Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z
    Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO
    Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J
    Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
    Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
    Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy.
    Sun Y; Zhao Y; Teng S; Hao F; Zhang H; Meng F; Zhao X; Zheng X; Bi Y; Yao Y; Lee RJ; Teng L
    Int J Nanomedicine; 2019; 14():135-148. PubMed ID: 30613142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.
    Mahalunkar S; Yadav AS; Gorain M; Pawar V; Braathen R; Weiss S; Bogen B; Gosavi SW; Kundu GC
    Int J Nanomedicine; 2019; 14():8285-8302. PubMed ID: 31802866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.